ImmunityBio, Inc. (IBRX) Huge Medical Breakthroughs

“To date four patients with Waldenstrom Non-Hodgkin Lymphoma have been enrolled and all remain in clinical disease control. Two patients are evaluable for long-term follow-up and continue to demonstrate durable complete remission at 7 and 15 months and ongoing, respectively, despite receiving no additional treatment after the initial eight doses of immunotherapy.”

Incredible buy and hold, I’m older and know we’ll pay any cost price to fix something like this without Chemotherapy

https://ca.finance.yahoo.com/news/immunitybio-announces-durable-complete-response-120000191.html